Title: Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024
Date: 2024-12-02 (Monday)
Type: Lords Chamber
Location: Lords Chamber
House: Lords

Speakers:
- Lord Cryer (Labour, Life peer)
  Topics: Healthcare and Social Welfare
  Subtopics: National Health Service (NHS), Pharmaceutical Policy and Drug Pricing

Tone: collaborative

Summary:
The House of Lords approved new amendments to the Human Medicines Regulations to facilitate modular manufacturing and point-of-care innovations, as recommended by the Secondary Legislation Scrutiny Committee.
Labour peer Lord Cryer moved the motion indicating cross-party acceptance of the regulatory changes, which were previously considered in a detailed Grand Committee session.
The unanimous agreement suggests a shared political commitment to modernising medical manufacturing frameworks, with potential positive implications for healthcare delivery efficiency and accessibility.

Topics:
Healthcare and Social Welfare:
  National Health Service (NHS), Pharmaceutical Policy and Drug Pricing

Key Points:
Lord Cryer (Labour, Life peer):
    Lord Cryer moved the motion to approve the draft Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024, acknowledging they were laid before the House on 21 October. This motion was considered in the Grand Committee on 28 November and referenced the 6th Report from the Secondary Legislation Scrutiny Committee.
    
Keywords: Human Medicines Regulations 2024, modular manufacture, point of care, Secondary Legislation Scrutiny Committee, Grand Committee